These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 25786697)

  • 21. Therapeutic opportunities for liver X receptor modulators.
    Collins JL
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):692-702. PubMed ID: 15503871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological role of liver X receptors.
    Baranowski M
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 7():31-55. PubMed ID: 19258656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting liver X receptors in inflammation.
    Steffensen KR; Jakobsson T; Gustafsson JÅ
    Expert Opin Ther Targets; 2013 Aug; 17(8):977-90. PubMed ID: 23738533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver X receptors in lipid metabolism: opportunities for drug discovery.
    Hong C; Tontonoz P
    Nat Rev Drug Discov; 2014 Jun; 13(6):433-44. PubMed ID: 24833295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver X receptors as potential targets for cancer therapeutics.
    Ju X; Huang P; Chen M; Wang Q
    Oncol Lett; 2017 Dec; 14(6):7676-7680. PubMed ID: 29250170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver X Receptor Inverse Agonist GAC0001E5 Impedes Glutaminolysis and Disrupts Redox Homeostasis in Breast Cancer Cells.
    Premaratne A; Ho C; Basu S; Khan AF; Bawa-Khalfe T; Lin CY
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The LXRs: a new class of oxysterol receptors.
    Peet DJ; Janowski BA; Mangelsdorf DJ
    Curr Opin Genet Dev; 1998 Oct; 8(5):571-5. PubMed ID: 9794827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.
    Pascual-García M; Rué L; León T; Julve J; Carbó JM; Matalonga J; Auer H; Celada A; Escolà-Gil JC; Steffensen KR; Pérez-Navarro E; Valledor AF
    J Immunol; 2013 Jun; 190(12):6520-32. PubMed ID: 23686490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feeding probiotic Lactobacillus paracasei to Ossabaw pigs on a high-fat diet prevents cholesteryl-ester accumulation and LPS modulation of the Liver X receptor and inflammatory axis in alveolar macrophages.
    Trasino SE; Dawson HD; Urban JF; Wang TT; Solano-Aguilar G
    J Nutr Biochem; 2013 Nov; 24(11):1931-9. PubMed ID: 24060267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver X receptor as a drug target for the treatment of breast cancer.
    Wu Y; Yu DD; Yan DL; Hu Y; Chen D; Liu Y; Zhang HD; Yu SR; Cao HX; Feng JF
    Anticancer Drugs; 2016 Jun; 27(5):373-82. PubMed ID: 26872310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of lipopolysaccharide-induced gene expression by liver X receptor ligands in macrophages involves interference with early growth response factor 1.
    Guillem-Llobat P; Íñiguez MA
    Prostaglandins Leukot Essent Fatty Acids; 2015 May; 96():37-49. PubMed ID: 25736222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxysterol receptors and their therapeutic applications in cancer conditions.
    De Boussac H; Alioui A; Viennois E; Dufour J; Trousson A; Vega A; Guy L; Volle DH; Lobaccaro JM; Baron S
    Expert Opin Ther Targets; 2013 Sep; 17(9):1029-38. PubMed ID: 23875732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipids, LXRs and prostate cancer: are HDACs a new link?
    Hoang JJ; Baron S; Volle DH; Lobaccaro JM; Trousson A
    Biochem Pharmacol; 2013 Jul; 86(1):168-74. PubMed ID: 23618920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver X receptors as potential therapeutic targets in atherosclerosis.
    Zhu Y; Li Y
    Clin Invest Med; 2009 Oct; 32(5):E383-94. PubMed ID: 19796580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of liver X receptor signaling as novel therapy for prostate cancer.
    Chuu CP; Kokontis JM; Hiipakka RA; Liao S
    J Biomed Sci; 2007 Sep; 14(5):543-53. PubMed ID: 17372849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the liver X receptors in skin physiology: Putative pharmacological targets in human diseases.
    Ouedraogo ZG; Fouache A; Trousson A; Baron S; Lobaccaro JA
    Chem Phys Lipids; 2017 Oct; 207(Pt B):59-68. PubMed ID: 28259649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in liver X receptor biology and chemistry.
    Goodwin BJ; Zuercher WJ; Collins JL
    Curr Top Med Chem; 2008; 8(9):781-91. PubMed ID: 18537688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver X receptors induce antiproliferative effects in basal-like breast cancer.
    Haugen MH; von der Lippe Gythfeldt H; Egeland EV; Svartdal Normann L; Pandya AD; Vedin LL; Juell S; Tenstad E; Øy GF; Kristian A; Marangoni E; Sørlie T; Steffensen K; Maelandsmo GM; Engebraaten O
    Mol Oncol; 2023 Oct; 17(10):2041-2055. PubMed ID: 37341140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver X receptors, lipids and their reproductive secrets in the male.
    El-Hajjaji FZ; Oumeddour A; Pommier AJ; Ouvrier A; Viennois E; Dufour J; Caira F; Drevet JR; Volle DH; Baron S; Saez F; Lobaccaro JM
    Biochim Biophys Acta; 2011 Aug; 1812(8):974-81. PubMed ID: 21334438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver X receptors as integrators of metabolic and inflammatory signaling.
    Zelcer N; Tontonoz P
    J Clin Invest; 2006 Mar; 116(3):607-14. PubMed ID: 16511593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.